Joseph B. Margolick

Active 1987–2025

139
Papers
35,711
Citations
95
h-index
135
i10-index

Citations

Citations per year for Joseph B. Margolick1948: 1 citations1967: 1 citations1986: 4 citations1987: 4 citations1988: 7 citations1989: 7 citations1990: 6 citations1991: 8 citations1992: 8 citations1993: 11 citations1994: 23 citations1995: 29 citations1996: 54 citations1997: 73 citations1998: 184 citations1999: 208 citations2000: 237 citations2001: 245 citations2002: 253 citations2003: 252 citations2004: 246 citations2005: 256 citations2006: 211 citations2007: 252 citations2008: 280 citations2009: 285 citations2010: 300 citations2011: 331 citations2012: 367 citations2013: 384 citations2014: 306 citations2015: 322 citations2016: 337 citations2017: 221 citations2018: 245 citations2019: 896 citations2020: 934 citations2021: 798 citations2022: 580 citations2023: 425 citations2024: 659 citations2025: 233 citations2026: 1 citations1949–1966: no citations, so these years are not shown1968–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,318 citing papers, 40.4% of this breakdownUnited Kingdom: 626 citing papers, 5.9% of this breakdownChina: 584 citing papers, 5.5% of this breakdownCanada: 449 citing papers, 4.2% of this breakdownFrance: 413 citing papers, 3.9% of this breakdownItaly: 361 citing papers, 3.4% of this breakdownAustralia: 355 citing papers, 3.3% of this breakdownGermany: 329 citing papers, 3.1% of this breakdownSpain: 287 citing papers, 2.7% of this breakdownNetherlands: 263 citing papers, 2.4% of this breakdownSwitzerland: 257 citing papers, 2.4% of this breakdownSouth Africa: 213 citing papers, 2% of this breakdown
0%40.4%Other 20.8%

Fields

  • Immunology and Microbiology48%
  • Medicine37.2%
  • Biochemistry, Genetics and Molecular Biology10.1%
  • Neuroscience1.1%
  • Mathematics0.4%
  • Psychology0.4%
  • Other2.8%

Topics

  • HIV Research and Treatment18.4%
  • HIV/AIDS Research and Interventions9%
  • HIV/AIDS drug development and treatment8.2%
  • Immune Cell Function and Interaction6.4%
  • HIV-related health complications and treatments5.2%
  • T-cell and B-cell Immunology2.5%
  • Other50.3%

Coauthors

All papers

Open in search
  1. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2019 cited by 768

  2. Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

    Authors: , , , , , , , , , , , , , , - Science 1997 cited by 3,138

  3. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

    Authors: , , , , , , , , - Nature Medicine 2003 cited by 1,739

  4. Epigenetic therapy inhibits metastases by disrupting premetastatic niches

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen Broderick, Stephen M. Cattaneo, Julie R. Brahmer, Charles M. Rudin, John Wrangle, Yuping Mei, Young J. Kim, Bin Zhang, Ken Kang‐Hsin Wang, Patrick M. Forde, Joseph B. Margolick, Barry D. Nelkin, Cynthia A. Zahnow, Drew M. Pardoll, Franck Housseau, Stephen B. Baylin, Lin Shen, Malcolm V. Brock - Nature 2020 cited by 337

  5. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

    Authors: , , , , , , , , , , , , , , - Nature 1997 cited by 2,067

  6. Aging in COVID-19: Vulnerability, immunity and intervention

    Authors: , , , , , , , , , - Ageing Research Reviews 2020 cited by 1,054

  7. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

    Authors: , , , , , , , , , , , , , , , , - Nature Medicine 1999 cited by 2,141

  8. Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of the International AIDS Society 2020 cited by 243

  9. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 702

  10. Antigen-driven clonal selection shapes the persistence of HIV-1–infected CD4+ T cells in vivo

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 cited by 176

  11. In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency

    Authors: , , , , , - Nature Medicine 1995 cited by 788

  12. Cardiac fibroblasts mediate IL-17A–driven inflammatory dilated cardiomyopathy

    Authors: , , , , , , , , , , , , - The Journal of Experimental Medicine 2014 cited by 182

  13. Signature changes in gut microbiome are associated with increased susceptibility to HIV-1 infection in MSM

    Authors: , , , , , , , , , , , , - Microbiome 2021 cited by 78

  14. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation

    Authors: , , , , , , , - AIDS 2014 cited by 384

  15. Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection

    Authors: , , , , , , , , , , , , , , , , , , - Immunity 2017 cited by 184

  16. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature 2015 cited by 501

  17. Consistent Viral Evolutionary Changes Associated with the Progression of Human Immunodeficiency Virus Type 1 Infection

    Authors: , , , , , , , , , , , - Journal of Virology 1999 cited by 956

  18. Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation

    Authors: , , , , , , , , , - Immunity 2012 cited by 707

  19. Characteristics of the MACS/WIHS Combined Cohort Study: Opportunities for Research on Aging With HIV in the Longest US Observational Study of HIV

    Authors: , , , , , , , , , , , , , , , , , - American Journal of Epidemiology 2021 cited by 150

  20. A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christina Wyatt, Zipporah Krishnasami, James Hellinger, Joseph B. Margolick, Lawrence Kingsley, Mallory D. Witt, Steven M. Wolinsky, Tariq Shafi, Wendy S. Post, Alessandro Doria, Hans‐Henrik Parving - American Journal of Kidney Diseases 2020 cited by 75

  21. HIV-1 Infection Is Associated With an Earlier Occurrence of a Phenotype Related to Frailty

    Authors: , , , , , , - The Journals of Gerontology Series A 2007 cited by 416

  22. Resting CD4+T Cells from Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals Carry Integrated HIV-1 Genomes within Actively Transcribed Host Genes

    Authors: , , , , , , , , , - Journal of Virology 2004 cited by 325

  23. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation

    Authors: , , , , , , , , , , , , - Journal of Clinical Investigation 2009 cited by 264

  24. Abdominal obesity, sarcopenia, and osteoporosis are associated with frailty in men living with and without HIV

    Authors: , , , , , , , , , , - AIDS 2018 cited by 77